Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Debt to Equity (2016 - 2025)

Conmed (CNMD) has disclosed Debt to Equity for 16 consecutive years, with $0.81 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity fell 14.1% year-over-year to $0.81, compared with a TTM value of $0.81 through Dec 2025, down 14.1%, and an annual FY2025 reading of $0.81, down 14.1% over the prior year.
  • Debt to Equity was $0.81 for Q4 2025 at Conmed, down from $0.85 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.46 in Q2 2022 and bottomed at $0.81 in Q4 2025.
  • Average Debt to Equity over 5 years is $1.09, with a median of $1.02 recorded in 2021.
  • The sharpest move saw Debt to Equity skyrocketed 62.31% in 2022, then fell 21.28% in 2025.
  • Year by year, Debt to Equity stood at $0.87 in 2021, then soared by 62.31% to $1.41 in 2022, then dropped by 17.49% to $1.17 in 2023, then fell by 19.4% to $0.94 in 2024, then fell by 14.1% to $0.81 in 2025.
  • Business Quant data shows Debt to Equity for CNMD at $0.81 in Q4 2025, $0.85 in Q3 2025, and $0.88 in Q2 2025.